Table 3 Characteristics of patients with or without potential drug-drug interactions
Patients without potential drug-drug interactions (n = 228) | Patients with potential drug-drug interactions (n = 296) | ||||
|---|---|---|---|---|---|
n (%) / Mean ± SD | n (%) / Mean ± SD | ||||
Age | 64.6 | 13.2 | 64.2 | 12.3 | |
Sex | Male | 179 | (78.5) | 232 | (78.4) |
Female | 49 | (21.5) | 64 | (21.6) | |
Place of residence | Germany | 178 | (78.1) | 275 | (92.9) |
Switzerland | 50 | (21.9) | 21 | (7.1) | |
Race | White | 214 | (93.9) | 287 | (97.0) |
Black | 3 | (1.3) | 1 | (0.3) | |
Asian | 2 | (0.9) | 4 | (1.4) | |
Unknown | 9 | (3.9) | 4 | (1.4) | |
Number of comorbidities | 0 | 43 | (18.9) | 65 | (22.0) |
1 | 84 | (36.8) | 110 | (37.2) | |
2 | 69 | (30.3) | 74 | (25.0) | |
3 | 29 | (12.7) | 37 | (12.5) | |
4 | 3 | (1.3) | 8 | (2.7) | |
5 | 0 | (0) | 2 | (0.7) | |
Most frequent comorbidities | Hypertension | 161 | (70.6) | 198 | (66.9) |
Diabetes | 64 | (28.1) | 92 | (31.1) | |
Stroke/TIA | 25 | (11.0) | 34 | (11.5) | |
COPD | 21 | (9.2) | 32 | (10.8) | |
Peripheral arterial disease | 19 | (8.3) | 26 | (8.8) | |
Number of taken drugs | 1.5 | 1.3 | 5.3 | 2.1 | |